Drugs firm accused over 6,000% price hike
A drugs firm abused its dominant market position to overcharge the NHS millions for an essential thyroid treatment, the UK’s competition watchdog has provisionally found. The amount charged by Concordia for a pack of the drug, liotyhronine, rose by almost 6,000%